Basit öğe kaydını göster

Middle East Treatment Strategies and Clinical Outcomes in Patients with Atrial Fibrillation: One-Year Follow-up Data from Garfield-AF Study

dc.contributor.authorSayin, Begum Yetis
dc.contributor.authorKakkar, Ajay K.
dc.contributor.authorVirdone, Saverio
dc.contributor.authorElbahry, Atef
dc.contributor.authorRagy, Hany Ibrahim
dc.contributor.authorAl Mahmeed, Wael
dc.contributor.authorErsanli, Murat
dc.contributor.authorOto, Ali
dc.date.accessioned2021-12-10T11:37:13Z
dc.date.available2021-12-10T11:37:13Z
dc.identifier.citationSayin B. Y. , Al Mahmeed W., Ragy H. I. , Elbahry A., Virdone S., Kakkar A. K. , Ersanli M., Oto A., "Middle East Treatment Strategies and Clinical Outcomes in Patients with Atrial Fibrillation: One-Year Follow-up Data from Garfield-AF Study", ADVANCES IN THERAPY, 2021
dc.identifier.issn0741-238X
dc.identifier.othervv_1032021
dc.identifier.otherav_8a06cbcc-5bd5-4823-853b-bfc824740cd9
dc.identifier.urihttp://hdl.handle.net/20.500.12627/172271
dc.identifier.urihttps://doi.org/10.1007/s12325-021-01670-5
dc.description.abstractIntroduction: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) aims to determine real-life treatment patterns and clinical outcomes of patients with newly diagnosed non-valvular atrial fibrillation (AF) and at least one investigator-determined risk factor for stroke. The registry includes a wide array of baseline characteristics and has a particular focus on: (1) bleeding and thromboembolic events; (2) international normalized ratio fluctuations; and (3) therapy compliance and persistence patterns.
dc.language.isoeng
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTemel Bilimler
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectPharmacology
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectReviews and References (medical)
dc.subjectPharmacology (medical)
dc.subjectResearch and Theory
dc.subjectPharmacy
dc.subjectDrug Guides
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectDahili Tıp Bilimleri
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.titleMiddle East Treatment Strategies and Clinical Outcomes in Patients with Atrial Fibrillation: One-Year Follow-up Data from Garfield-AF Study
dc.typeMakale
dc.relation.journalADVANCES IN THERAPY
dc.contributor.departmentMemorial Healthcare Group , ,
dc.contributor.firstauthorID2606993


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster